Could a bacterial extract slash antibiotic use in High-Risk bladder patients?
NCT ID NCT06588010
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a daily pill made from bacterial proteins (OM-89) can reduce the number of antibiotics needed for urinary tract infections in adults with neurogenic bladder who use catheters. About 110 participants will receive either OM-89 or a placebo for one year. The goal is to see if this approach lowers infection-related antibiotic use and helps fight antibiotic resistance.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROGENIC BLADDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Dijon Bourgogne
RECRUITINGDijon, 21000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New catheter design aims to make Self-Catheterization easier and more comfortable
- Shockingly simple: wearable zaps aim to end bladder leaks for paralyzed men
- Bladder wash could cut infections and hospital visits for catheter users
- Decades of data: does this bladder surgery stand the test of time for spinal cord injury?
- New registry tracks Real-Life catheter experiences to improve bladder care
- Antibiotics after bladder botox may cut infection risk